Hong Kong Pharma Digital Technology (NASDAQ:HKPD) Stock Price Down 0.7% – Time to Sell?

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) shares traded down 0.7% during mid-day trading on Thursday . The company traded as low as $0.6977 and last traded at $0.6977. 20,380 shares were traded during trading, a decline of 68% from the average session volume of 64,043 shares. The stock had previously closed at $0.7026.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hong Kong Pharma Digital Technology in a research report on Friday, January 9th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Hong Kong Pharma Digital Technology presently has an average rating of “Sell”.

Hong Kong Pharma Digital Technology Stock Performance

The firm has a 50 day simple moving average of $0.79 and a 200-day simple moving average of $1.06.

Institutional Investors Weigh In On Hong Kong Pharma Digital Technology

An institutional investor recently bought a new position in Hong Kong Pharma Digital Technology stock. StoneX Group Inc. bought a new position in shares of Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 43,284 shares of the company’s stock, valued at approximately $36,000. StoneX Group Inc. owned about 0.39% of Hong Kong Pharma Digital Technology as of its most recent filing with the Securities & Exchange Commission.

Hong Kong Pharma Digital Technology Company Profile

Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.